Effects of Raltegravir (Isentress®) on Lipid and Carbohydrate Metabolism and Mitochondrial Function in Healthy Volunteers

Update Il y a 4 ans
Reference: NCT00772720

  • | Country :
  • Spain
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Raltegravir is the first of a new antiretroviral class. A better profile of metabolic toxicity is expected. In order to better define its effects, without interference with other drugs, a study on healthy volunteers is warranted.


Inclusion criteria

  • Healthy Volunteers

Links